ZYLOX-TONBRDG.MED.TECH.H1 (818) — Cash Flow-to-Debt Ratio
ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Cash Flow-to-Debt Ratio of 0.50x as of December 2024, meaning its operating cash flow of €174.08 Million could theoretically repay 0% of its total liabilities (€351.56 Million) in one year. See 818 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ZYLOX-TONBRDG.MED.TECH.H1 Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for ZYLOX-TONBRDG.MED.TECH.H1 across 4 annual periods. Also explore 818 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
Year-by-year debt coverage analysis for ZYLOX-TONBRDG.MED.TECH.H1. For market capitalisation and broader financial context, see market value of ZYLOX-TONBRDG.MED.TECH.H1.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | €174.08 Million | €351.56 Million | ▲ +65.1% |
| 2023 | 0.30x | €98.44 Million | €328.32 Million | ▲ +152.4% |
| 2022 | -0.57x | €-91.32 Million | €159.54 Million | ▲ +49.0% |
| 2021 | -1.12x | €-116.21 Million | €103.61 Million | — |